US Stock MarketDetailed Quotes

MYNZ Mainz Biomed

Watchlist
  • 0.740
  • +0.003+0.45%
Close May 6 16:00 ET
  • 0.770
  • +0.030+4.05%
Pre 08:00 ET
16.20MMarket Cap-456P/E (TTM)

About Mainz Biomed Company

Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.

Company Profile

SymbolMYNZ
Company NameMainz Biomed
Listing DateNov 5, 2021
Issue Price5.00
Founded2021
CEOMr. Guido Baechler
MarketNASDAQ
Employees71
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressSirius Gutenberg Park,Robert Koch Strasse 50
CityMainz
ProvinceRheinland-Pfalz
CountryGermany
Zip Code55129
Phone49-6131-55428-60
Websitehttp://mainzbiomed.com

Company Executives

  • Name
  • Position
  • Salary
  • Guido Baechler
  • Chief Executive Officer and Director
  • --
  • Darin Leigh
  • Chief Commercial Officer
  • --
  • Dr. Frank Krieg-Schneider
  • Chief Technology Officer
  • --
  • William J. Caragol
  • Chief Financial Officer
  • --
  • Philipp Freese
  • Chief Business Officer
  • --
  • Dr. Moritz Eidens
  • Chief Scientific Officer and Director
  • --
  • Dr. Chris von Toerne
  • Chief Operating Officer
  • --
  • Hans Hekland
  • Independent Director
  • --
  • Gregory J. Tibbitts
  • Independent Director
  • --
  • Dr. Alberto Libanori, PhD
  • Independent Director
  • --
  • Dr. Heiner Dreismann,PhD
  • Independent Director
  • --
  • Nicole Holden
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg